Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005141327 | SCV005764198 | pathogenic | Ataxia-telangiectasia-like disorder | 2024-08-31 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser268Lysfs*23) in the MRE11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MRE11 are known to be pathogenic (PMID: 23080121, 23912341). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MRE11-related conditions. For these reasons, this variant has been classified as Pathogenic. |